Hereditary and Familial Colon Cancer

Lichtenstein, 2000, Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland, N Engl J Med, 343, 78, 10.1056/NEJM200007133430201 Grady, 2003, Genetic testing for high-risk colon cancer patients, Gastroenterology, 124, 1574, 10.1016/S0016-5085(03)00376-7 Lynch, 2003, Hereditary colorectal cancer, N Engl J Med, 348, 919, 10.1056/NEJMra012242 Hampel, 2008, Feasibility of screening for Lynch syndrome among patients with colorectal cancer, J Clin Oncol, 26, 5783, 10.1200/JCO.2008.17.5950 Stoffel, 2009, Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome, Gastroenterology, 137, 1621, 10.1053/j.gastro.2009.07.039 Ribic, 2003, Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer, N Engl J Med, 349, 247, 10.1056/NEJMoa022289 Hampel, 2006, Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients, Cancer Res, 66, 7810, 10.1158/0008-5472.CAN-06-1114 Rustgi, 2007, The genetics of hereditary colon cancer, Genes Dev, 21, 2525, 10.1101/gad.1593107 Kastrinos, 2009, Risk of pancreatic cancer in families with Lynch syndrome, JAMA, 302, 1790, 10.1001/jama.2009.1529 Peltomaki, 2004, Mutations associated with HNPCC predisposition—update of ICG-HNPCC/INSiGHT mutation database, Dis Markers, 20, 269, 10.1155/2004/305058 Plaschke, 2004, Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium, J Clin Oncol, 22, 4486, 10.1200/JCO.2004.02.033 Senter, 2008, The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations, Gastroenterology, 135, 419, 10.1053/j.gastro.2008.04.026 Kovacs, 2009, Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome, Hum Mutat, 30, 197, 10.1002/humu.20942 Ligtenberg, 2009, Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1, Nat Genet, 41, 112, 10.1038/ng.283 Niessen, 2009, Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome, Genes Chromosomes Cancer, 48, 737, 10.1002/gcc.20678 Backes, 2009, Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer, Gynecol Oncol, 114, 486, 10.1016/j.ygyno.2009.05.026 Stupart, 2009, Surveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutation, Colorectal Dis, 11, 126, 10.1111/j.1463-1318.2008.01702.x Järvinen, 2000, Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer, Gastroenterology, 118, 829, 10.1016/S0016-5085(00)70168-5 Burn, 2009, Aspirin prevents cancer in Lynch syndrome, Eur J Cancer Suppl, 7, 320, 10.1016/S1359-6349(09)71095-X Schmeler, 2006, Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome, N Engl J Med, 354, 261, 10.1056/NEJMoa052627 Kwon, 2008, Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome, Cancer, 113, 326, 10.1002/cncr.23554 Lynch, 2009, Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management, Mol Oncol, 3, 97, 10.1016/j.molonc.2009.02.004 Burt, 2004, Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis, Gastroenterology, 127, 444, 10.1053/j.gastro.2004.05.003 Burt, 2003, Gastric fundic gland polyps, Gastroenterology, 125, 1462, 10.1016/j.gastro.2003.07.017 Bianchi, 2008, Fundic gland polyp dysplasia is common in familial adenomatous polyposis, Clin Gastroenterol Hepatol, 6, 180, 10.1016/j.cgh.2007.11.018 Bulow, 2004, Duodenal adenomatosis in familial adenomatous polyposis, Gut, 53, 381, 10.1136/gut.2003.027771 Speake, 2007, Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations, Br J Surg, 94, 1009, 10.1002/bjs.5633 Knudsen, 2003, Attenuated familial adenomatous polyposis (AFAP), Fam Cancer, 2, 43, 10.1023/A:1023286520725 Hes, 2008, Somatic APC mosaicism: an underestimated cause of polyposis coli, Gut, 57, 71, 10.1136/gut.2006.117796 Nieuwenhuis, 2007, Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature, Crit Rev Oncol Hematol, 61, 153, 10.1016/j.critrevonc.2006.07.004 Guillem, 2006, ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes, J Clin Oncol, 24, 4642, 10.1200/JCO.2005.04.5260 Rattner, 1996, Defining the criteria for local resection of ampullary neoplasms, Arch Surg, 131, 366, 10.1001/archsurg.1996.01430160024003 Gallagher, 2006, Surveillance and management of upper gastrointestinal disease in familial adenomatous polyposis, Fam Cancer, 5, 263, 10.1007/s10689-005-5668-0 Herraiz, 2007, Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations, Clin Gastroenterol Hepatol, 5, 367, 10.1016/j.cgh.2006.10.019 Lubbe, 2009, Clinical implications of the colorectal cancer risk associated with MUTYH mutation, J Clin Oncol, 27, 3975, 10.1200/JCO.2008.21.6853 Cleary, 2009, Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study, Gastroenterology, 136, 1251, 10.1053/j.gastro.2008.12.050 Boparai, 2008, Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis, Gastroenterology, 135, 2014, 10.1053/j.gastro.2008.09.020 Vogt, 2009, Expanded extracolonic tumor spectrum in MUTYH-associated polyposis, Gastroenterology, 137, 1976, 10.1053/j.gastro.2009.08.052 Schreibman, 2005, The hamartomatous polyposis syndromes: a clinical and molecular review, Am J Gastroenterol, 100, 476, 10.1111/j.1572-0241.2005.40237.x Pilarski, 2009, Cowden syndrome: a critical review of the clinical literature, J Genet Couns, 18, 13, 10.1007/s10897-008-9187-7 McGarrity, 2006, Peutz-Jeghers syndrome: clinicopathology and molecular alterations, Cell Mol Life Sci, 63, 2135, 10.1007/s00018-006-6080-0 Gammon, 2009, Hamartomatous polyposis syndromes, Best Pract Res Clin Gastroenterol, 23, 219, 10.1016/j.bpg.2009.02.007 Brosens, 2007, Risk of colorectal cancer in juvenile polyposis, Gut, 56, 965, 10.1136/gut.2006.116913 Volikos, 2006, LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome, J Med Genet, 43, e18, 10.1136/jmg.2005.039875 Boparai, 2009, Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study, Gut Yeoman, 2007, Hyperplastic polyposis in the New Zealand population: a condition associated with increased colorectal cancer risk and European ancestry, N Z Med J, 120, U2827 Chow, 2006, Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH, Gastroenterology, 131, 30, 10.1053/j.gastro.2006.03.046 Jass, 2007, Gastrointestinal polyposes: clinical, pathological and molecular features, Gastroenterol Clin North Am, 36, 927, 10.1016/j.gtc.2007.08.009 Snover, 2005, Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept, Am J Clin Pathol, 124, 380, 10.1309/V2EPTPLJRB3FGHJL Minoo, 2006, Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis, Gut, 55, 1467, 10.1136/gut.2005.082859 Young, 2006, The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature, Cancer Epidemiol Biomarkers Prev, 15, 1778, 10.1158/1055-9965.EPI-06-0164 Adler, 2009, Narrow-band versus white-light high definition television endoscopic imaging for screening colonoscopy: a prospective randomized trial, Gastroenterology, 136, 410, 10.1053/j.gastro.2008.10.022 Doran, 2009, Prophylactic colectomy for hyperplastic polyposis, Ir J Med Sci Kerber, 2005, Frequency of familial colon cancer and hereditary nonpolyposis colorectal cancer in a large population database, Fam Cancer, 4, 239, 10.1007/s10689-005-0657-x Lindor, 2005, Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X, JAMA, 293, 1979, 10.1001/jama.293.16.1979 Mueller-Koch, 2005, Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer, Gut, 54, 1733, 10.1136/gut.2004.060905 Johns, 2001, A systematic review and meta-analysis of familial colorectal cancer risk, Am J Gastroenterol, 96, 2992, 10.1111/j.1572-0241.2001.04677.x Neklason, 2008, Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis, Cancer Res, 68, 8993, 10.1158/0008-5472.CAN-08-1376 Wiesner, 2003, A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2, Proc Natl Acad Sci U S A, 100, 12961, 10.1073/pnas.2132286100 Kemp, 2006, Evidence for a colorectal cancer susceptibility locus on chromosome 3q21-q24 from a high-density SNP genome-wide linkage scan, Hum Mol Genet, 15, 2903, 10.1093/hmg/ddl231 Djureinovic, 2006, A genome wide linkage analysis in Swedish families with hereditary non-familial adenomatous polyposis/non-hereditary non-polyposis colorectal cancer, Gut, 55, 362, 10.1136/gut.2005.075333 Jaeger, 2008, Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk, Nat Genet, 40, 26, 10.1038/ng.2007.41 Daley, 2008, Identification of susceptibility genes for cancer in a genome-wide scan: results from the colon neoplasia sibling study, Am J Hum Genet, 82, 723, 10.1016/j.ajhg.2008.01.007 Dermitzakis, 2009, Genetics, Science, 326, 239, 10.1126/science.1182009 Winawer, 2003, Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence, Gastroenterology, 124, 544, 10.1053/gast.2003.50044 Tenesa, 2009, New insights into the aetiology of colorectal cancer from genome-wide association studies, Nat Rev Genet, 10, 353, 10.1038/nrg2574 Tenesa, 2008, Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21, Nat Genet, 40, 631, 10.1038/ng.133 Curtin, 2009, Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21, Cancer Epidemiol Biomarkers Prev, 18, 616, 10.1158/1055-9965.EPI-08-0690 Hardy, 2009, Genomewide association studies and human disease, N Engl J Med, 360, 1759, 10.1056/NEJMra0808700 Houlston, 2001, Polymorphisms and colorectal tumor risk, Gastroenterology, 121, 282, 10.1053/gast.2001.26265 Huang, 2006, GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a population-based case-control study in North Carolina (United States), Cancer Causes Control, 17, 385, 10.1007/s10552-005-0424-1 Ritchie, 2009, Markedly enhanced colon tumorigenesis in ApcMin mice lacking glutathione S-transferase Pi, Proc Natl Acad Sci U S A, 10.1073/pnas.0911351106 Folsom, 2008, Variation in TCF7L2 and increased risk of colon cancer: the Atherosclerosis Risk in Communities (ARIC) Study, Diabetes Care, 31, 905, 10.2337/dc07-2131 Hazra, 2008, Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk, Cancer Causes Control, 19, 975, 10.1007/s10552-008-9164-3 Morimoto, 2005, Insulin-like growth factor polymorphisms and colorectal cancer risk, Cancer Epidemiol Biomarkers Prev, 14, 1204, 10.1158/1055-9965.EPI-04-0695 Xu, 2007, TGF-beta signaling alterations and susceptibility to colorectal cancer, Hum Mol Genet, 16, R14, 10.1093/hmg/ddl486 Zeng, 2009, Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development, Cancer Res, 69, 678, 10.1158/0008-5472.CAN-08-3980 Broderick, 2007, A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk, Nat Genet, 39, 1315, 10.1038/ng.2007.18 Wijnen, 2009, Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome, Gastroenterology, 136, 131, 10.1053/j.gastro.2008.09.033 Reeves, 2008, IGF1 is a modifier of disease risk in hereditary non-polyposis colorectal cancer, Int J Cancer, 123, 1339, 10.1002/ijc.23668 Shi, 2009, Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age, Int J Cancer, 125, 78, 10.1002/ijc.24304 Feliz, 2006, GSTM1 and GSTT1 polymorphisms as modifiers of age at diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) in a homogeneous cohort of individuals carrying a single predisposing mutation, Mutat Res, 602, 175, 10.1016/j.mrfmmm.2006.09.004 Crabtree, 2004, Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases, Gut, 53, 271, 10.1136/gut.2003.015586 Rennert, 2005, Colorectal polyps in carriers of the APC I1307K polymorphism, Dis Colon Rectum, 48, 2317, 10.1007/s10350-005-0167-9 Zauber, 2003, The characterization of somatic APC mutations in colonic adenomas and carcinomas in Ashkenazi Jews with the APC I1307K variant using linkage disequilibrium, J Pathol, 199, 146, 10.1002/path.1226 Tranah, 2005, APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma, Cancer Epidemiol Biomarkers Prev, 14, 863, 10.1158/1055-9965.EPI-04-0687 Tulupova, 2008, Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?, Mutat Res, 648, 40, 10.1016/j.mrfmmm.2008.09.005 Allan, 2008, MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer, Int J Cancer, 123, 2456, 10.1002/ijc.23770 Koushik, 2006, p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer, Int J Cancer, 119, 1863, 10.1002/ijc.22057 Schernhammer, 2006, Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma, Br J Cancer, 94, 928, 10.1038/sj.bjc.6603007 Dong, 2009, Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk, Cancer Epidemiol Biomarkers Prev, 18, 2540, 10.1158/1055-9965.EPI-09-0228 Ding, 2008, Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: reanalysis of Women's Health Initiative randomized trial, Int J Cancer, 122, 1690, 10.1002/ijc.23311 Roff, 2008, A novel SNP in a vitamin D response element of the CYP24A1 promoter reduces protein binding, transactivation, and gene expression, J Steroid Biochem Mol Biol, 112, 47, 10.1016/j.jsbmb.2008.08.009 Peters, 2008, Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma, Cancer Epidemiol Biomarkers Prev, 17, 1144, 10.1158/1055-9965.EPI-07-2947 Peters, 2006, High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program, Cancer Epidemiol Biomarkers Prev, 15, 315, 10.1158/1055-9965.EPI-05-0471 Barry, 2006, Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention, J Natl Cancer Inst, 98, 1494, 10.1093/jnci/djj398 Gerner, 2005, A comprehensive strategy to combat colon cancer targeting the adenomatous polyposis coli tumor suppressor gene, Ann N Y Acad Sci, 1059, 97, 10.1196/annals.1339.033 Spain, 2009, Colorectal cancer risk is not associated with increased levels of homozygosity in a population from the United Kingdom, Cancer Res, 69, 7422, 10.1158/0008-5472.CAN-09-0659 Webb, 2009, A genome-wide scan of 10 000 gene-centric variants and colorectal cancer risk, Eur J Hum Genet, 17, 1507, 10.1038/ejhg.2009.92 Goodman, 2006, Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis, Int J Cancer, 118, 1790, 10.1002/ijc.21523